13 results
·
22ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
REMEX-GR100
FDA 510(k)
FDA Class 2
·Dental
Philips
FDA UDI
Sbo Hearing A/S·05714464058471·HEARLINK 3030 MNR T GR/DG
NIM Vital, Nerve Integrity Monitor
FDA 510(k)
FDA Class 2
·Neurology
BENGAL SYSTEM, BENGAL STACKABLE SYSTEM, CONCORDE BULLET LUMBAR, CONCORDE INLINE LUMBAR, COUGAR SYSTEM, COUGAR LS LATERAL
FDA 510(k)
FDA Class 2
·Orthopedic
UNIFY ASSURA CRT-D
FDA Adverse Event
Malfunction
·ST. JUDE MEDICAL, INC., CRMD·Product code NIK·November 10, 2014
ZIMMER NEXGEN COMPLETE KNEE SOLUTION LEGACY LPS
FDA Adverse Event
Injury
·ZIMMER, INC.·Product code MBH·September 4, 2011
ONETOUCHPING GLUCOSEMGMTSYSTEM
FDA Adverse Event
Malfunction
·ANIMAS CORPORATION·Product code LZG·July 22, 2013
PATIENT INTERFACE NIM4CPB1 NIM 4.0
FDA Adverse Event
Malfunction
·MEDTRONIC XOMED INC.·Product code GWF·October 28, 2025
STIMULATOR, ELECTRICAL, EVOKED RESPONSE
FDA Adverse Event
Malfunction
·MEDTRONIC XOMED INC.·Product code GWF·July 31, 2023
NIM 4.0 CONSOLE
FDA Adverse Event
Malfunction
·MEDTRONIC XOMED INC.·Product code GWF·September 5, 2025
NIM 4.0 CONSOLE
FDA Adverse Event
Malfunction
·MEDTRONIC XOMED INC.·Product code GWF·August 2, 2024
NIM 4.0 CONSOLE
FDA Adverse Event
Malfunction
·MEDTRONIC XOMED INC.·Product code GWF·May 20, 2025
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014